APA (7th ed.) Citation

Neelamegan, R., Saka, V., Tamilarasu, K., Rajaram, M., Selvarajan, S., & Chandrasekaran, A. (2016). Clinical Utility of Fractional exhaled Nitric Oxide (FeNO) as a Biomarker to Predict Severity of Disease and Response to Inhaled Corticosteroid (ICS) in Asthma Patients. JCDR Research and Publications Private Limited.

Chicago Style (17th ed.) Citation

Neelamegan, Revathy, Vinodkumar Saka, Kadhiravan Tamilarasu, Manju Rajaram, Sandhiya Selvarajan, and Adithan Chandrasekaran. Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) as a Biomarker to Predict Severity of Disease and Response to Inhaled Corticosteroid (ICS) in Asthma Patients. JCDR Research and Publications Private Limited, 2016.

MLA (8th ed.) Citation

Neelamegan, Revathy, et al. Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) as a Biomarker to Predict Severity of Disease and Response to Inhaled Corticosteroid (ICS) in Asthma Patients. JCDR Research and Publications Private Limited, 2016.